SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2000-Year of the Biotechs! -- Ignore unavailable to you. Want to Upgrade?


To: Arthur Radley who wrote (247)2/8/2000 10:20:00 AM
From: Jack Hartmann  Read Replies (2) | Respond to of 1142
 
SCLN has two promising products Zadaxin and CPX. Zadaxin is an immune system booster which they are using for Hepatitis C and B and it's generating revenues for them abroad.
CPX is their hope for a cure for cystic fibrosis. Phase 2 may be completed this spring.
They 8 straight quarters of revenue growth and last year grew revenues at 150%. They are looking to be profitable in the last quater of year 2000.
Jack